STRIvE-01: EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults

SCRI-CARB7H3(s)x19 - Seattle Children's Hospital

EGFR806-specific CAR T-cell therapy - Cellevolve Bio, Seattle Children’s Therapeutics

http://clinicaltrials.gov/ct2/show/NCT03618381

Nov 21, 2025